About Cell BioEngines
Cell BioEngines is a company based in Worcester (United States) founded in 2020 by Samuel Casey, Alexey Bersenev, Nathan Johnson, and Ajay Vishwakarma.. Cell BioEngines has raised $2.53 million across 2 funding rounds from investors including New York State, SOSV and IndieBio. Cell BioEngines offers products and services including Stem Cell-based Platform and Allogeneic Cell Therapies. Cell BioEngines operates in a competitive market with competitors including Moderna, BeiGene, Incyte, Horizon Therapeutics and Forge Biologics, among others.
- Headquarter Worcester, United States
- Founders Samuel Casey, Alexey Bersenev, Nathan Johnson, Ajay Vishwakarma
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cell Bioengines, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.53 M (USD)
in 2 rounds
-
Latest Funding Round
$2 M (USD), Seed
Jul 20, 2024
-
Investors
New York State
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cell BioEngines
Cell BioEngines offers a comprehensive portfolio of products and services, including Stem Cell-based Platform and Allogeneic Cell Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for expanding and differentiating stem cells for clinical use.
Therapies targeting tumors using natural biology and off-the-shelf cells.
Funding Insights of Cell BioEngines
Cell BioEngines has successfully raised a total of $2.53M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $2 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Seed — $2.0M
-
First Round
First Round
(13 Sep 2023)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Seed - Cell BioEngines | Valuation | SOSV , New York State |
|
| Sep, 2023 | Amount | Seed - Cell BioEngines | Valuation | IndieBio |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cell BioEngines
Cell BioEngines has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include New York State, SOSV and IndieBio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and accelerator services are provided across multiple sectors.
|
Founded Year | Domain | Location | |
|
Biotech startups are accelerated through IndieBio's focused programs.
|
Founded Year | Domain | Location | |
|
Provides the information about government agencies in New York
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cell BioEngines
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cell BioEngines
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cell Bioengines Comparisons
Competitors of Cell BioEngines
Cell BioEngines operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BeiGene, Incyte, Horizon Therapeutics and Forge Biologics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for treating rare and autoimmune diseases
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Therapeutic antibodies for cancer and other diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cell Bioengines
Frequently Asked Questions about Cell BioEngines
When was Cell BioEngines founded?
Cell BioEngines was founded in 2020 and raised its 1st funding round 3 years after it was founded.
Where is Cell BioEngines located?
Cell BioEngines is headquartered in Worcester, United States. It is registered at Worcester, Massachusetts, United States.
Who is the current CEO of Cell BioEngines?
Ajay Vishwakarma is the current CEO of Cell BioEngines. They have also founded this company.
Is Cell BioEngines a funded company?
Cell BioEngines is a funded company, having raised a total of $2.53M across 2 funding rounds to date. The company's 1st funding round was a Seed of $525K, raised on Sep 13, 2023.
What does Cell BioEngines do?
Founded in 2020 and based in Worcester, United States, cell therapies are developed by the company for oncology, tissue degeneration, and immune-related diseases. Proprietary live allogenic cell therapies are utilized, treating stem or immune cells as drugs. The BioEngine platform is employed, encompassing BioACCESS, BioANALYTICS, BioASSAYS, and BioMAN. Next-generation cell therapy companies are supported through the Cell BioVentures model. A drug candidate, MS-101, is advanced for SARS-related COVID-19 infections.
Who are the top competitors of Cell BioEngines?
What products or services does Cell BioEngines offer?
Cell BioEngines offers Stem Cell-based Platform and Allogeneic Cell Therapies.
Who are Cell BioEngines's investors?
Cell BioEngines has 3 investors. Key investors include New York State, SOSV, and IndieBio.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.